Cargando…
Buccal Midazolam Solution for the Management of Prolonged Acute Convulsive Seizures: A Cost Analysis
BACKGROUND: There is little published evidence on how pack size impacts on health system costs. In the UK, children and adolescents aged 10 to < 18 years with prolonged acute convulsive seizures (PACS) occurring in the community setting are usually managed by the administration of buccal midazola...
Autores principales: | Ludwig, Catherine, Fisher, Lauri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018870/ https://www.ncbi.nlm.nih.gov/pubmed/31292935 http://dx.doi.org/10.1007/s41669-019-0164-x |
Ejemplares similares
-
Buccal midazolam for pediatric convulsive seizures: efficacy, safety, and patient acceptability
por: Anderson, Mark
Publicado: (2013) -
Nasal and Buccal Treatment of Midazolam in Epileptic Seizures in Pediatrics
por: Ülgey, Ayşe, et al.
Publicado: (2012) -
A Comparison of Buccal Midazolam and Intravenous Diazepam for the Acute Treatment of Seizures in Children
por: Tonekaboni, Seyed-Hassan, et al.
Publicado: (2012) -
A comparison of the cost-effectiveness of treatment of prolonged acute convulsive epileptic seizures in children across Europe
por: Lee, Dawn C, et al.
Publicado: (2014) -
Convulsive Seizures
por: Kahn, Eugen
Publicado: (1943)